GeneDx Holdings (WGSWW) Return on Sales (2020 - 2026)

GeneDx Holdings has disclosed Return on Sales across 7 years of filings, most recently posting 0.01% for Q1 2026.

• In Q1 2026, Return on Sales fell 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales eased to 0.01% in Q1 2026, from 0.0% in the prior quarter.
• Over the last five years, Return on Sales for WGSWW reached as high as 0.0% in Q2 2025 and fell as low as 0.05% in Q4 2022.
• The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.01%.
• Annual changes were most pronounced in 2022 — Return on Sales decreased 4 bps — and 2023, when it climbed 5 bps.
• A 5-year view of Return on Sales shows it stood at 0.05% in 2022, then soared by 91 bps to 0.0% in 2023, then surged by 113 bps to 0.0% in 2024, then sank by 357 bps to 0.0% in 2025, then tumbled by 323 bps to 0.01% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.01%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.